DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Apaziquone is an investigational drug.
There have been 9 clinical trials for Apaziquone. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Urinary Bladder Neoplasms and [disabled in preview]. The leading clinical trial sponsors are Spectrum Pharmaceuticals, Inc, Allergan, and Handok Pharmaceuticals Co., Ltd.
Recent Clinical Trials for Apaziquone
|A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Patients Undergoing TURBT||Spectrum Pharmaceuticals, Inc||Phase 3|
|A Study of Intravesical Apaziquone as a Surgical Adjuvant in Patient Undergoing TURBT||Spectrum Pharmaceuticals, Inc||Phase 3|
|Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)||Handok Pharmaceuticals Co., Ltd.||Phase 2/Phase 3|